Published in Biomaterials on March 01, 2000
Biomimetic hydrogels with pro-angiogenic properties. Biomaterials (2010) 1.98
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Biomaterials in orthopaedics. J R Soc Interface (2008) 1.78
Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev (2009) 1.45
Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat (2007) 1.31
Tissue engineering of functional articular cartilage: the current status. Cell Tissue Res (2011) 1.29
The role of tissue engineering in articular cartilage repair and regeneration. Crit Rev Biomed Eng (2009) 1.23
Computational predictions of the tensile properties of electrospun fibre meshes: effect of fibre diameter and fibre orientation. J Mech Behav Biomed Mater (2008) 1.22
Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater (2009) 1.21
Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials (2009) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Multilayered silk scaffolds for meniscus tissue engineering. Biomaterials (2010) 1.18
Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials (2012) 1.17
Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol (2011) 1.14
In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials (2009) 1.13
Chondrogenic differentiation of human mesenchymal stem cells on oriented nanofibrous scaffolds: engineering the superficial zone of articular cartilage. Tissue Eng Part A (2009) 1.09
Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. J Control Release (2013) 1.08
A rapid seeding technique for the assembly of large cell/scaffold composite constructs. Tissue Eng (2006) 1.03
Polymeric nanofibers in tissue engineering. Tissue Eng Part B Rev (2011) 1.03
Hyaline cartilage engineered by chondrocytes in pellet culture: histological, immunohistochemical and ultrastructural analysis in comparison with cartilage explants. J Anat (2004) 1.00
Controlled proteolytic cleavage site presentation in biomimetic PEGDA hydrogels enhances neovascularization in vitro. Tissue Eng Part A (2012) 0.94
Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater (2010) 0.94
Hydrogels for osteochondral repair based on photocrosslinkable carbamate dendrimers. Biomacromolecules (2008) 0.92
Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One (2013) 0.92
Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells. J Mater Sci Mater Med (2005) 0.92
Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res (2016) 0.92
Nondestructive assessment of engineered cartilage constructs using near-infrared spectroscopy. Appl Spectrosc (2010) 0.91
Enhancing chondrogenic phenotype for cartilage tissue engineering: monoculture and coculture of articular chondrocytes and mesenchymal stem cells. Tissue Eng Part B Rev (2014) 0.90
Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique. J Mater Sci Mater Med (2007) 0.85
Application of stem cells in bone repair. Skeletal Radiol (2008) 0.85
Perspectives on the interface of drug delivery and tissue engineering. Adv Drug Deliv Rev (2012) 0.85
Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs. Adv Mater (2012) 0.84
Acrylic scaffolds with interconnected spherical pores and controlled hydrophilicity for tissue engineering. J Mater Sci Mater Med (2005) 0.83
A polylactide/fibrin gel composite scaffold for cartilage tissue engineering: fabrication and an in vitro evaluation. J Mater Sci Mater Med (2008) 0.83
Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization. Adv Funct Mater (2014) 0.83
Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers for cartilage tissue engineering. PLoS One (2013) 0.83
Variation of mesenchymal cells in polylactic acid scaffold in an osteochondral repair model. Tissue Eng Part C Methods (2009) 0.83
A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects. J Mater Sci Mater Med (2011) 0.82
Development and Characterization of Acellular Extracellular Matrix Scaffolds from Porcine Menisci for Use in Cartilage Tissue Engineering. Tissue Eng Part C Methods (2015) 0.82
Silk Biomaterials with Vascularization Capacity. Adv Funct Mater (2015) 0.81
Fabrication of tissue engineering scaffolds through solid-state foaming of immiscible polymer blends. Biofabrication (2011) 0.81
A novel in vitro bovine cartilage punch model for assessing the regeneration of focal cartilage defects with biocompatible bacterial nanocellulose. Arthritis Res Ther (2013) 0.81
Collagen scaffolds with controlled insulin release and controlled pore structure for cartilage tissue engineering. Biomed Res Int (2014) 0.81
A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes. J Mater Sci Mater Med (2007) 0.81
Ultrasonic bioreactor as a platform for studying cellular response. Tissue Eng Part C Methods (2012) 0.80
Mechanically induced structural changes during dynamic compression of engineered cartilaginous constructs can potentially explain increases in bulk mechanical properties. J R Soc Interface (2011) 0.80
Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules. PLoS One (2015) 0.80
A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures. Biores Open Access (2012) 0.80
Annulus fibrosus tissue engineering using lamellar silk scaffolds. J Tissue Eng Regen Med (2012) 0.80
Surface zone articular chondrocytes modulate the bulk and surface mechanical properties of the tissue-engineered cartilage. Tissue Eng Part A (2014) 0.79
Evaluation of three-dimensional chitosan-agarose-gelatin cryogel scaffold for the repair of subchondral cartilage defects: an in vivo study in a rabbit model. Tissue Eng Part A (2014) 0.79
Chondrogenic phenotype of articular chondrocytes in monoculture and co-culture with mesenchymal stem cells in flow perfusion. Tissue Eng Part A (2014) 0.78
Fabrication of porous scaffolds with a controllable microstructure and mechanical properties by porogen fusion technique. Int J Mol Sci (2011) 0.78
Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditions. Tissue Eng Part A (2014) 0.77
Biomaterials for tissue engineering. Ann Biomed Eng (2013) 0.77
Development of porous collagen beads for chondrocyte culture. Cytotechnology (2006) 0.77
Engineering complex orthopaedic tissues via strategic biomimicry. Ann Biomed Eng (2014) 0.77
Characterisation of freeze-dried type II collagen and chondroitin sulfate scaffolds. J Mater Sci Mater Med (2013) 0.77
Evaluating Osteoarthritic Chondrocytes through a Novel 3-Dimensional In Vitro System for Cartilage Tissue Engineering and Regeneration. Cartilage (2012) 0.77
Effect of Dynamic Culture and Periodic Compression on Human Mesenchymal Stem Cell Proliferation and Chondrogenesis. Ann Biomed Eng (2015) 0.76
The Therapeutic Potential of Exogenous Adenosine Triphosphate (ATP) for Cartilage Tissue Engineering. Cartilage (2012) 0.76
Treating Proximal Tibial Growth Plate Injuries Using Poly(Lactic-co-Glycolic Acid) Scaffolds. Biores Open Access (2015) 0.76
Simulating the growth of articular cartilage explants in a permeation bioreactor to aid in experimental protocol design. J Biomech Eng (2009) 0.76
Selective cell proliferation can be controlled with CPC particle coatings. J Biomed Mater Res A (2007) 0.76
The effect of 3D nanofibrous scaffolds on the chondrogenesis of induced pluripotent stem cells and their application in restoration of cartilage defects. PLoS One (2014) 0.75
Harnessing cell–biomaterial interactions for osteochondral tissue regeneration. Adv Biochem Eng Biotechnol (2012) 0.75
Expression of hedgehog signal pathway in articular cartilage is associated with the severity of cartilage damage in rats with adjuvant-induced arthritis. J Inflamm (Lond) (2015) 0.75
Acrylamide Polymer Double-Network Hydrogels: Candidate Cartilage Repair Materials with Cartilage-Like Dynamic Stiffness and Attractive Surgery-Related Attachment Mechanics. Cartilage (2011) 0.75
Synergistic effect of ascorbic acid and collagen addition on the increase in type 2 collagen accumulation in cartilage-like MSC sheet. Cytotechnology (2015) 0.75
Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration. Stem Cell Res Ther (2017) 0.75
Near infrared spectroscopic assessment of developing engineered tissues: correlations with compositional and mechanical properties. Analyst (2016) 0.75
Effect of porosities of bilayered porous scaffolds on spontaneous osteochondral repair in cartilage tissue engineering. Regen Biomater (2015) 0.75
Fibroin and fibroin blended three-dimensional scaffolds for rat chondrocyte culture. Biomed Eng Online (2013) 0.75
Matrilin-3 Role in Cartilage Development and Osteoarthritis. Int J Mol Sci (2016) 0.75
Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro. Sci Rep (2017) 0.75
Effect of chitosan incorporation and scaffold geometry on chondrocyte function in dense collagen type I hydrogels. Tissue Eng Part A (2013) 0.75
Differences in joint morphology between the knee and ankle affect the repair of osteochondral defects in a rabbit model. J Orthop Surg Res (2016) 0.75
Tissue Engineering of Cartilage; Can Cannabinoids Help? Pharmaceuticals (Basel) (2010) 0.75
Study of carbon nano-tubes effects on the chondrogenesis of human adipose derived stem cells in alginate scaffold. Int J Prev Med (2014) 0.75
Experimental study of tissue-engineered cartilage allograft with RNAi chondrocytes in vivo. Ther Clin Risk Manag (2014) 0.75
Differential effects of tyrosine-rich amelogenin peptide on chondrogenic and osteogenic differentiation of adult chondrocytes. Cell Tissue Res (2015) 0.75
Design of a microscopic electrical impedance tomography system for 3D continuous non-destructive monitoring of tissue culture. Biomed Eng Online (2014) 0.75
Adsorption and distribution of fluorescent solutes near the articular surface of mechanically injured cartilage. Biophys J (2013) 0.75
Gelatin-based Hydrogel Degradation and Tissue Interaction in vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice. Theranostics (2016) 0.75
Evaluation of chitosan-GP hydrogel biocompatibility in osteochondral defects: an experimental approach. BMC Vet Res (2014) 0.75
Preclinical investigations of articular cartilage ablation with femtosecond and pulsed infrared lasers as an alternative to microfracture surgery. J Biomed Opt (2014) 0.75
Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications. ACS Biomater Sci Eng (2015) 0.75
Intrinsic Osteoinductivity of Porous Titanium Scaffold for Bone Tissue Engineering. Int J Biomater (2017) 0.75
Selective laser sintering scaffold with hierarchical architecture and gradient composition for osteochondral repair in rabbits. Biomaterials (2017) 0.75
Silk fibroin/cartilage extracellular matrix scaffolds with sequential delivery of TGF-β3 for chondrogenic differentiation of adipose-derived stem cells. Int J Nanomedicine (2017) 0.75
Thermosensitive Poly(N-vinylcaprolactam) Injectable Hydrogels for Cartilage Tissue Engineering. Tissue Eng Part A (2017) 0.75
Protein based therapeutic delivery agents: Contemporary developments and challenges. Biomaterials (2017) 0.75
Advanced Strategies for Articular Cartilage Defect Repair. Materials (Basel) (2013) 0.75
A Dual-Bonded Approach for Improving Hydrogel Implant Stability in Cartilage Defects. Materials (Basel) (2017) 0.75
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications. Pharmaceuticals (Basel) (2017) 0.75
Synthesis of mesoporous structured hydroxyapatite particles using yeast cells as the template. J Mater Sci Mater Med (2010) 0.75
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Growing new organs. Sci Am (1999) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Recent progress in gene delivery using non-viral transfer complexes. J Control Release (2001) 1.00
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am (2001) 0.97
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 0.97
Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res (1997) 0.95
Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater (2010) 0.94
Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release. Biomaterials (1995) 0.93
Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng (1999) 0.92
Characterization of partially saturated poly(propylene fumarate) for orthopaedic application. J Biomater Sci Polym Ed (1997) 0.92
Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res (2000) 0.91
Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials (2001) 0.91
Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur Cell Mater (2011) 0.90
Degradation and biocompatibility of a poly(propylene fumarate)-based/alumoxane nanocomposite for bone tissue engineering. J Biomed Mater Res A (2007) 0.90
Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A (2008) 0.90
Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant (1999) 0.89
Modulation of marrow stromal cell function using poly(D,L-lactic acid)-block-poly(ethylene glycol)-monomethyl ether surfaces. J Biomed Mater Res (1999) 0.89
Biodegradable fumarate-based drug-delivery systems for ophthalmic applications. J Biomed Mater Res A (2009) 0.89
Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomater Sci Polym Ed (1998) 0.88
Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater (2011) 0.88
In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1998) 0.87
Poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng (2003) 0.87
Retinal pigment epithelial cell adhesion on novel micropatterned surfaces fabricated from synthetic biodegradable polymers. Biomaterials (2001) 0.86
In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta Biomater (2009) 0.85
Integrin alpha(v)beta(3) is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. J Cell Biochem (2001) 0.85
Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1997) 0.83
Preparation of macroporous poly(2-hydroxyethyl methacrylate) hydrogels by enhanced phase separation. Biomaterials (2000) 0.83
Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop Relat Res (1999) 0.82
Osseointegration of preformed polymethylmethacrylate craniofacial prostheses coated with bone marrow-impregnated poly (DL-lactic-co-glycolic acid) foam. Plast Reconstr Surg (1999) 0.82
Cell seeding in porous transplantation devices. Biomaterials (1993) 0.82
Retinal pigment epithelial cell function on substrates with chemically micropatterned surfaces. Biomaterials (1999) 0.80
Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers. J Control Release (2006) 0.80
Guided bone growth in sheep: a model for tissue-engineered bone flaps. Tissue Eng (1996) 0.80
PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym Ed (2008) 0.80
Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro. Biomaterials (1998) 0.79
Effect of macromer molecular weight on in vitro ophthalmic drug release from photo-crosslinked matrices. Acta Biomater (2007) 0.79
Intra-articular microparticles for drug delivery to the TMJ. J Dent Res (2010) 0.79
Retinal pigment epithelium cell culture on thin biodegradable poly(DL-lactic-co-glycolic acid) films. J Biomater Sci Polym Ed (1998) 0.78
An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2. J Cell Biochem (2001) 0.77
Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials (1996) 0.77
Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems. J Biomed Mater Res A (2007) 0.77
Cells for drug delivery platforms. Adv Drug Deliv Rev (2000) 0.75
Osteoblast migration on poly(alpha-hydroxy esters). Biotechnol Bioeng (1996) 0.75
Dynamics of fibrovascular tissue ingrowth in hydrogel foams. Cell Transplant (1995) 0.75
Preparation and Use of Porous Poly(α-Hydroxyester) Scaffolds for Bone Tissue Engineering. Methods Mol Med (1999) 0.75
The growth and phenotypic expression of human osteoblasts. Cytotechnology (1996) 0.75
Letter from the editors. Tissue Eng (1995) 0.75
Biodegradable polymers. Sci Med (Phila) (2001) 0.75
Diffusion-controlled delivery of proteins from hydrogels and other hydrophilic systems. Pharm Biotechnol (1997) 0.75
Biomaterials for tissue engineering: summary. Tissue Eng (1997) 0.75